Endothelin induces rapid, dynamin-mediated budding of endothelial caveolae rich in ET-B.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 3366858)

Published in J Biol Chem on March 28, 2012

Authors

Phil Oh1, Thierry Horner, Halina Witkiewicz, Jan E Schnitzer

Author Affiliations

1: Proteogenomics Research Institute for Systems Medicine, San Diego, California 92121, USA.

Articles cited by this

Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell (2006) 13.15

Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol (2001) 8.93

Endocytosis. Physiol Rev (1997) 7.33

Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev (2001) 6.50

Regulated internalization of caveolae. J Cell Biol (1994) 5.77

Dynamin-mediated internalization of caveolae. J Cell Biol (1998) 5.26

Separation of caveolae from associated microdomains of GPI-anchored proteins. Science (1995) 5.25

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A (1988) 4.77

Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science (1994) 4.36

Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol (1994) 4.30

Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature (1982) 4.22

Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol (1998) 3.99

Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A (1996) 3.83

Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem (1996) 3.75

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54

Nucleotide-dependent conformational changes in dynamin: evidence for a mechanochemical molecular spring. Nat Cell Biol (1999) 3.28

Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24

Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol Biol Cell (2002) 2.84

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation (1994) 2.69

Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci U S A (2006) 2.61

Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem (1995) 2.41

Transcytosis of albumin in capillary endothelium. J Cell Biol (1987) 2.33

Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun (1994) 2.08

Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell (2001) 2.02

Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science (1996) 1.95

Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci U S A (1994) 1.88

Detergent-insoluble glycosphingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae (review). Mol Membr Biol (1999) 1.82

Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J Biol Chem (1997) 1.79

Cellular trafficking of G protein-coupled receptor/beta-arrestin endocytic complexes. J Biol Chem (1999) 1.53

In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem (1998) 1.48

Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A (2002) 1.43

Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem (2000) 1.38

Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension (1998) 1.37

Cholesterol oxidation switches the internalization pathway of endothelin receptor type A from caveolae to clathrin-coated pits in Chinese hamster ovary cells. J Biol Chem (2000) 1.36

Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem (1997) 1.36

Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc Natl Acad Sci U S A (2000) 1.30

Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein betagamma subunit signaling to protein jinase B/Akt. J Biol Chem (2003) 1.29

Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev (2001) 1.28

Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem (2000) 1.27

Vesicular transport in capillary endothelium: does it occur? Fed Proc (1983) 1.26

Immunoisolation of caveolae with high affinity antibody binding to the oligomeric caveolin cage. Toward understanding the basis of purification. J Biol Chem (1999) 1.26

Agonist-induced redistribution of bradykinin B2 receptor in caveolae. J Cell Sci (1998) 1.14

Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling. EMBO J (2000) 1.10

Role of endothelin in cardiovascular disease. J Renin Angiotensin Aldosterone Syst (2002) 1.09

Involvement of caveolin in ligand-induced recruitment and internalization of A(1) adenosine receptor and adenosine deaminase in an epithelial cell line. Mol Pharmacol (2001) 1.05

Colocalization of beta-adrenergic receptors and caveolin within the plasma membrane. J Cell Biochem (1999) 0.99

Biochemical and proteomic approaches for the study of membrane microdomains. J Proteomics (2008) 0.98

Caveolae require intact VAMP for targeted transport in vascular endothelium. Am J Physiol (1999) 0.98

Regulated interaction of endothelin B receptor with caveolin-1. Eur J Biochem (2003) 0.98

Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor. Mol Pharmacol (2000) 0.97

Muscarinic cholinergic signaling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation. Life Sci (1999) 0.89

Endothelin-induced endocytosis of cell surface ETA receptors. Endothelin remains intact and bound to the ETA receptor. J Biol Chem (1995) 0.88

Agonist-independent internalization of metabotropic glutamate receptor 1a is arrestin- and clathrin-dependent and is suppressed by receptor inverse agonists. J Neurochem (2004) 0.84

ETB receptors on aortic smooth muscle cells of spontaneously hypertensive rats. Am J Physiol (1993) 0.83

Endothelin-1 induces rapid and long lasting internalization of the thrombin receptor in human glomerular epithelial cells. Biochem Biophys Res Commun (1995) 0.82

Articles by these authors

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54

Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24

Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol (2009) 3.01

Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98

Caveolae: mining little caves for new cancer targets. Nat Rev Cancer (2003) 1.76

Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am J Physiol Heart Circ Physiol (2003) 1.47

Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci U S A (2005) 1.46

Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A (2002) 1.43

Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol (2002) 1.21

Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.10

Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc Natl Acad Sci U S A (2009) 1.00

Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol Cell Proteomics (2009) 0.99

Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium. Am J Physiol Heart Circ Physiol (2004) 0.97

Application of capture-recapture models to estimation of protein count in MudPIT experiments. Anal Chem (2006) 0.96

Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo. J Biol Chem (2009) 0.95

T cell pathways involving CTLA4 contribute to a model of acute lung injury. J Immunol (2010) 0.94

Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol (2009) 0.92

Transient mechanoactivation of neutral sphingomyelinase in caveolae to generate ceramide. J Biol Chem (2002) 0.90

Role of caveolae and lipid rafts in cancer: workshop summary and future needs. Cancer Res (2003) 0.90

Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int J Nanomedicine (2010) 0.90

Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex. J Am Chem Soc (2013) 0.89

Genomics and proteomics of lung disease: conference summary. Am J Physiol Lung Cell Mol Physiol (2007) 0.88

Assessing the barriers to image-guided drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.86

Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues. Mol Cell Proteomics (2010) 0.84

Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat. J Vasc Res (2009) 0.83

Caveolae and cancer. Recent Results Cancer Res (2010) 0.82

Targeting and imaging signature caveolar molecules in lungs. Proc Am Thorac Soc (2009) 0.81

Streamlining biomarker discovery. Nat Biotechnol (2011) 0.79

Chapter 8. Proteomic mapping of the vascular endothelium in vivo for vascular targeting. Methods Enzymol (2008) 0.79

Laser-targeted photosensitizer-induced lung injury: noninvasive rat model of pulmonary infarction. Exp Lung Res (2011) 0.76

Range Charts for Agreement in Measurement Comparison Studies, With Application to Replicate Mass Spectrometry Experiments. J Proteomics Bioinform (2008) 0.76

Systems analysis of endothelial cell plasma membrane proteome of rat lung microvasculature. Proteome Sci (2011) 0.76

Tumor targeting, trifunctional dendritic wedge. Bioconjug Chem (2014) 0.75

Construction of metabolically biotinylated adenovirus with deleted fiber knob as targeting vector. Virol J (2010) 0.75

Experimental model of transthoracic, vascular-targeted, photodynamically induced myocardial infarction. Am J Physiol Heart Circ Physiol (2013) 0.75